Comparison of changes in serum inflammatory cytokines and lipid levels after oral administration of rosuvastatin and simvastatin in patients with end-stage renal disease receiving high-throughput maintenance hemodialysis
XU Fang
NIE Daqing
CHEN Wenli
Abstract:Objective To compare the changes in serum inflammatory cytokines and lipid levels after oral administration of rosuvastatin and simvastatin in patients with end-stage renal disease receiving high-throughput maintenance hemodialysis.Methods Seventy-eight patients with end-stage renal disease were randomly divided into the rosuvastatin group and simvastatin group.Patients in the two groups received high-throughput maintenance hemodialysis, followed by oral administration of rosuvastatin in the rosuvastatin group and simvastatin in the simvastatin group.We compared the levels of serum inflammatory cytokines [high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6)] and lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C)].Results Compared with the simvastatin group, the levels of hs-CRP, IL-6, and TNF-α decreased after treatment in the rosuvastatin group (all P<0.05).The levels of hs-CRP, IL-6, and TNF-α significantly decreased after treatment in these two groups as compared with those before treatment (all P<0.05).Compared with the simvastatin group, LDL-C decreased after treatment in the rosuvastatin group (P<0.05).The levels of TC, TG, and LDL-C significantly decreased, while HDL-C increased after treatment in these two groups as compared with those before treatment (all P<0.05).Conclusion Both rosuvastatin and simvastatin can decrease the levels of hs-CRP, TNF-α, IL-6, TC, and TG, and increase the LDL-C level, but the efficacy of rosuvastatin is better than that of simvastatin.
Keywords:rosuvastatinsimvastatinhigh-sensitivity C-reactive proteintumor necrosis factor-αinterleukin-6total cholesteroltriglyceridelow-density lipoprotein cholesterolhigh-density lipoprotein cholesterol
Publication Date:2017-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:4( 25-28 )
Shandong Medical Journal

Shandong Medical Journal

PKUISTIC
ISSN:1002-266X
Year, Vol.(Issue):2017,57(31)